Product Code: GVR-1-68038-881-7
Protein Purification And Isolation Market Growth & Trends:
The global protein purification and isolation market size is expected to reach USD 19.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.6% from 2022 to 2030. Technological advancements and investments for the development of structure-based drugs by both private and public research organizations are driving the demand for protein purification and isolation products.
Furthermore, factors including the increased requirement to categorize R&D in the pharmaceutical, novel protein-based medicinal compounds, and biotechnological segments are contributing to the growth of the market. Many elements contribute to the market growth including increasing funding for research and development from both commercial and public research bodies, as well as expanded research-based on structure-based drug plans. High purifying device costs and a scarcity of experienced specialists, on the other hand, are stifling the market's expansion. As the demand for protein therapeutics and novel legends for the drug development process rises, the market will experience opportunities.
Another major driver in the market is the growing need to accurately discover novel ligands and produce quick purification kits. The increasing desire for technologically better techniques is pushing up the demand for trustworthy identification of various new protein molecules and purification and separation of functional proteins with minimal contaminants. Rapid purification kits are required to shorten purification and isolation time while preserving efficacy. Because affinity tags allow for successful purification in one step, they are commonly used for protein isolation and purification. Body proteins are isolated in less than 60 minutes with ProteoSpin Inclusion Body Protein Isolation Kits. During the forecast period, these are the reasons that would drive the market.
The unanticipated COVID-19 pandemic caused the establishment of global lockdown rules, causing delays in protein purification and isolation import and export. The pandemic also reduced the availability of funds from private investors and governments worldwide. The disruption in the process during the pandemic had a severe impact on the market, but increased government investment in research and development is allowing the business to recover, and the market is likely to rise over the forecast period.
Protein Purification And Isolation Market Report Highlights:
- Based on product, the consumables segment dominated the market with a revenue share of over 60.0% in 2021 and is expected to witness significant growth over the forecast period pertaining to the high usage in cell lysis and increased commercialization of advanced resins
- On the basis of technology, chromatography emerged as the leading segment in 2021 with a revenue share of over 25.0% owing to the availability of a varied range of products, enhanced results for complex protein purification, and high reliability
- By application, the drug screening segment is estimated to be the fastest-growing application segment over the forecast period owing to factors such as high efficacy and increasing R&D investments by manufacturers for the screening of novel drugs
- In terms of end-use, the hospitals segment is projected to exhibit the fastest growth rate over the forecast period. This is attributed to the increasing adoption of protein purification techniques
- North America dominated the global market in 2021 with a revenue share of over 45.0% owing to factors such as established research infrastructure, the presence of major players, and technological advancements in the region
- Asia Pacific is estimated to register the highest CAGR over the forecast period due to the increasing economic stability, a growing number of CROs, and R&D activities in academic and research institutes
- Market players are adopting strategies such as the expansion of product portfolios through R&D initiatives, mergers, acquisitions, and strategic collaborations to further strengthen their position in the market
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Research Methodology
- 1.2 Research Assumptions
- 1.2.1 Estimates and Forecast Timeline
- 1.3 Research Methodology
- 1.4 Information Procurement
- 1.4.1 Purchased Database
- 1.4.2 GVR's Internal Database
- 1.4.3 Secondary Sources
- 1.4.4 Primary Research
- 1.4.5 Details of Primary Research
- 1.5 Information or Data Analysis
- 1.5.1 Data Analysis Models
- 1.6 Market Formulation & Validation
- 1.7 Model Details
- 1.7.1 Commodity Flow Analysis
- 1.7.1.1 Approach 1: Commodity Flow Approach
- 1.7.1.2 Approach 2: Country-wise market estimation using a bottom-up approach
- 1.8 Global Market: CAGR Calculation
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 Objectives
- 1.11.1 Objective 1
- 1.11.2 Objective 2
- 1.12 List of Tables
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
Chapter 4 Industry Outlook
- 4.1 Market Variable Analysis
- 4.1.1 Increase in investment in pharmaceutical and biotechnological R&D
- 4.1.2 Growing need for more accurate and rapid purification kits
- 4.1.3 Technological advancements
- 4.2 Market Restraint Analysis
- 4.2.1 High cost of purification instruments and lack of skilled professionals
- 4.3 Penetration and Growth Prospect Mapping
- 4.4 Regulatory Framework
- 4.4.1 Standards & compliances
- 4.5 Protein Purification and Isolation Market Analysis Tools
- 4.5.1 PESTEL Analysis
- 4.5.1.1 Political landscape
- 4.5.1.2 Environmental landscape
- 4.5.1.3 Social landscape
- 4.5.1.4 Technology landscape
- 4.5.1.5 Legal landscape
- 4.5.2 Industry analysis - Porter's
- 4.5.2.1 Supplier power (Moderate due to requirement of high-quality raw materials)
- 4.5.2.2 Buyer power (Moderate due to increasing demand for novel technologies)
- 4.5.2.3 Substitution threat (Low due to the accuracy requirements of the products)
- 4.5.2.4 New entrants' threat (High due to increasing number of companies)
- 4.5.2.5 Competitive rivalry (High due to the market is fragmented)
- 4.5.3 Major deals & strategic alliances analysis
- 4.5.3.1 Joint ventures
- 4.5.3.2 Mergers & acquisitions
- 4.5.3.3 Licensing & partnership
- 4.5.3.4 Technology collaborations
- 4.5.3.5 Strategic divestments
Chapter 5 Competitive Analysis
- 5.1 Recent Developments & Impact Analysis, by Key Market Participants
- 5.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
- 5.3 Vendor Landscape
- 5.3.1 List of key distributors
- 5.3.2 Key company market share analysis
- 5.4 Public Companies
- 5.4.1 Company market position analysis
- 5.4.2 Competitive dashboard analysis
- 5.5 Private Companies
- 5.5.1 List of key emerging companies /technology disruptors/innovators
- 5.5.2 Regional network map
Chapter 6 Product Business Analysis
- 6.1 Protein Purification and Isolation Market: Product Movement Analysis
- 6.2 Instruments
- 6.2.1 Instruments market estimates and forecast, 2017 - 2030
- 6.3 Consumables
- 6.3.1 Consumables market estimates and forecast, 2017 - 2030
- 6.3.2 Kits
- 6.3.2.1 Kits market estimates and forecast, 2017 - 2030
- 6.3.3 Reagents
- 6.3.3.1 Reagents market estimates and forecast, 2017 - 2030
- 6.3.4 Columns
- 6.3.4.1 Columns market estimates and forecast, 2017 - 2030
- 6.3.5 Magnetic beads
- 6.3.5.1 Magnetic beads market estimates and forecast, 2017 - 2030
- 6.3.6 Resins
- 6.3.6.1 Resins market estimates and forecast, 2017 - 2030
- 6.3.7 Others
- 6.3.7.1 Others market estimates and forecast, 2017 - 2030
Chapter 7 Technology Business Analysis
- 7.1 Protein Purification and Isolation Market: Technology Movement Analysis
- 7.2 Ultrafiltration
- 7.2.1 Ultrafiltration market estimates and forecast, 2017 - 2030
- 7.3 Precipitation
- 7.3.1 Precipitation market estimates and forecast, 2017 - 2030
- 7.4 Chromatography
- 7.4.1 Chromatography market estimates and forecast, 2017 - 2030
- 7.4.2 Ion exchange chromatography
- 7.4.2.1 Ion exchange chromatography market estimates and forecast, 2017 - 2030
- 7.4.3 Affinity Chromatography
- 7.4.3.1 Affinity chromatography market estimates and forecast, 2017 - 2030
- 7.4.4 Reversed phase chromatography
- 7.4.5 Reversed phase chromatography market estimates and forecast, 2017 - 2030
- 7.4.6 Size exclusion chromatography
- 7.4.7 Size exclusion chromatography market estimates and forecast, 2017 - 2030
- 7.4.8 Hydrophobic interaction chromatography (HIC)
- 7.4.9 Hydrophobic interaction chromatography market estimates and forecast, 2017 - 2030
- 7.5 Electrophoresis
- 7.5.1 Electrophoresis market estimates and forecast, 2017 - 2030
- 7.5.2 Gel electrophoresis
- 7.5.3 Gel electrophoresis market estimates and forecast, 2017 - 2030
- 7.5.4 Isoelectric focusing (IEF)
- 7.5.5 Isoelectric focusing (IEF) market estimates and forecast, 2017 - 2030
- 7.5.6 Capillary electrophoresis
- 7.5.7 Capillary electrophoresis market estimates and forecast, 2017 - 2030
- 7.6 Western Blotting
- 7.6.1 Western Blotting market estimates and forecast, 2017 - 2030
- 7.7 Others
- 7.7.1 Others market estimates and forecast, 2017 - 2030
Chapter 8 Application Business Analysis
- 8.1 Protein Purification and Isolation Market: Application Movement Analysis
- 8.2 Drug Screening
- 8.2.1 Drug screening market estimates and forecast, 2017 - 2030
- 8.3 Biomarker Discovery
- 8.3.1 Biomarker Discovery market estimates and forecast, 2017 - 2030
- 8.4 Protein-protein interaction studies
- 8.4.1 Protein-protein interaction studies market estimates and forecast, 2017 - 2030
- 8.5 Diagnostics
- 8.5.1 Diagnostics market estimates and forecast, 2017 - 2030
Chapter 9 End-use Business Analysis
- 9.1 Protein Purification and Isolation Market: End-use Movement Analysis
- 9.2 Academic and Research Institutes
- 9.2.1 Academic and research institutes market estimates and forecast, 2017 - 2030
- 9.3 Hospitals
- 9.3.1 Hospitals Market estimates and forecast, 2017 - 2030
- 9.4 Pharmaceutical and Biotechnological Companies
- 9.4.1 Pharmaceutical and Biotechnological companies Market estimates and forecast, 2017 - 2030
- 9.5 CROs
- 9.5.1 CRO Market estimates and forecast, 2017 - 2030
Chapter 10 Regional Business Analysis
- 10.1 Protein Purification and Isolation Market: Regional Movement Analysis
- 10.2 North America
- 10.2.1 North America, SWOT analysis
- 10.2.2 North America market estimates and forecast, 2017 - 2030
- 10.2.3 U.S.
- 10.2.3.1 U.S. market estimates and forecast, 2017 - 2030
- 10.2.4 Canada
- 10.2.4.1 Canada market estimates and forecast, 2017 - 2030
- 10.3 Europe
- 10.3.1 Europe, SWOT analysis
- 10.3.2 Europe market estimates and forecast, 2017 - 2030
- 10.3.3 Germany
- 10.3.3.1 Germany market estimates and forecast, 2017 - 2030
- 10.3.4 U.K.
- 10.3.4.1 U.K. market estimates and forecast, 2017 - 2030
- 10.3.5 France
- 10.3.5.1 France market estimates and forecast, 2017 - 2030
- 10.3.6 Spain
- 10.3.6.1 Spain market estimates and forecast, 2017 - 2030
- 10.3.7 Italy
- 10.3.7.1 Italy market estimates and forecast, 2017 - 2030
- 10.4 Asia Pacific
- 10.4.1 Asia Pacific, SWOT analysis
- 10.4.2 Asia Pacific market estimates and forecast, 2017 - 2030
- 10.4.3 Japan
- 10.4.3.1 Japan market estimates and forecast, 2017 - 2030
- 10.4.4 China
- 10.4.4.1 China market estimates and forecast, 2017 - 2030
- 10.4.5 India
- 10.4.5.1 India market estimates and forecast, 2017 - 2030
- 10.4.6 South Korea
- 10.4.6.1 South Korea market estimates and forecast, 2017 - 2030
- 10.5 Latin America
- 10.5.1 Latin America, SWOT analysis
- 10.5.2 Latin America market estimates and forecast, 2017 - 2030
- 10.5.3 Brazil
- 10.5.3.1 Brazil market estimates and forecast, 2017 - 2030
- 10.5.4 Mexico
- 10.5.4.1 Mexico market estimates and forecast, 2017 - 2030
- 10.5.5 Colombia
- 10.5.5.1 Colombia market estimates and forecast, 2017 - 2030
- 10.5.6 Chile
- 10.5.6.1 Chile market estimates and forecast, 2017 - 2030
- 10.6 MEA
- 10.6.1 MEA, SWOT analysis
- 10.6.2 MEA market estimates and forecast, 2017 - 2030
- 10.6.3 South Africa
- 10.6.3.1 South Africa market estimates and forecast, 2017 - 2030
- 10.6.4 UAE
- 10.6.4.1 UAE market estimates and forecast, 2017 - 2030
Chapter 11 Company Profiles
- 11.1 Company Profiles
- 11.1.1 Thermo Fischer Scientific Inc.
- 11.1.1.1 Company Overview
- 11.1.1.2 Financial Performance
- 11.1.1.3 Product Benchmarking
- 11.1.1.4 Strategic Initiatives
- 11.1.2 Merck KGaA
- 11.1.2.1 Company Overview
- 11.1.3 Sigma-Aldrich Corporation
- 11.1.3.1 Company Overview
- 11.1.3.2 Financial Performance
- 11.1.3.3 Product Benchmarking
- 11.1.3.4 Strategic Initiatives
- 11.1.4 QIAGEN
- 11.1.4.1 Company Overview
- 11.1.4.2 Financial Performance
- 11.1.4.3 Product Benchmarking
- 11.1.4.4 Strategic Initiatives
- 11.1.5 Bio-Rad Laboratories, Inc.
- 11.1.5.1 Company Overview
- 11.1.5.2 Financial Performance
- 11.1.5.3 Product Benchmarking
- 11.1.5.4 Strategic Initiatives
- 11.1.6 Agilent Technologies
- 11.1.6.1 Company Overview
- 11.1.6.2 Financial Performance
- 11.1.6.3 Product Benchmarking
- 11.1.6.4 Strategic Initiatives
- 11.1.7 Promega Corporation
- 11.1.7.1 Company Overview
- 11.1.7.2 Product Benchmarking
- 11.1.7.3 Strategic Initiatives
- 11.1.8 General Electric Company
- 11.1.8.1 Company Overview
- 11.1.8.2 Financial Performance
- 11.1.8.3 Product Benchmarking
- 11.1.8.4 Strategic Initiatives
- 11.1.9 Norgen Biotek Corp.
- 11.1.9.1 Company Overview
- 11.1.9.2 Product Benchmarking
- 11.1.10 Abcam plc
- 11.1.10.1 Company Overview
- 11.1.10.2 Financial Performance
- 11.1.10.3 Product Benchmarking
- 11.1.10.4 Strategic Initiatives